What is Context Therapeutics Inc (CNTX) stock price today?

Context Therapeutics Inc (CNTX) currently trades at $2.34 per share. The stock has a market capitalization of $207.65M and a P/E ratio of —x.

Is CNTX stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Context Therapeutics Inc has a Smart Value Score of 24/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is 3/9 and Altman Z-Score is —.

Is Context Therapeutics Inc financially healthy?

Context Therapeutics Inc's Piotroski F-Score is 3/9 (weak financial health). The Altman Z-Score of — places it in the —.

CNTX

Context Therapeutics Inc

NASDAQ: CNTX · HEALTHCARE · BIOTECHNOLOGY

$2.34

-6.77% today

Updated 2026-04-29

Market cap

$207.65M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-0.38

Dividend yield

—

52W range

$0 – $4

Volume

0.9M

Market cap

$207.65M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-0.38

Dividend yield

—

52W range

$0 – $4

Volume

0.9M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

7.3

Quality

B+

3.0

Profitability

5.0

Valuation

C+

3/9

Piotroski F-Score

Weak

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →202 stocks currently score above 75

Price targets

Analyst target

$6.00

+156.41%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

3 Strong Buy7 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

+ Debt/equity 0.00x — low leverage

Risks

- Piotroski 3/9 — weak financial health

- Thin margins at 0.00%

- Negative free cash flow $-8.94M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-14.84M	$-23.96M	$-26.73M	$-36.12M	$-13.03M
EPS	—	—	—	—	$-0.38
Free cash flow	$-14.09M	$-21.05M	$-29.31M	$-26.42M	$-8.94M
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
CNTX	$207.65M	24	4.3	3.0	5.0	7.3	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Context Therapeutics Inc trades at $2.34. Our Smart Value Score of 24/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score.

Frequently asked questions

What is Context Therapeutics Inc's stock price?

Context Therapeutics Inc (CNTX) trades at $2.34.

Is Context Therapeutics Inc overvalued?

Smart Value Score 24/100 (Grade F, Strong Sell).

What is the price target of Context Therapeutics Inc (CNTX)?

The analyst target price is $6.00, representing +156.4% upside from the current price of $2.34.

Piotroski F-Score?

3/9 — weak financial health.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

www.contexttherapeutics.com

Quick metrics

P/S ratio—

ROE-46.40%

Beta1.83

50D MA$2.61

200D MA$1.54

Shares out0.09B

Float0.04B

Short ratio—

Avg volume0.9M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

CNTX vs LLY →CNTX vs JNJ →CNTX vs ABBV →Stock screener →